Clinics in oncology (Belmont, Calif.)最新文献

筛选
英文 中文
Quantitative Evaluation of the Relationship between Magnetic Resonance Elastic Value and Pathological Grade of Hepatocellular Carcinoma by Magnetic Resonance Elastography 磁共振弹性成像定量评价肝细胞癌磁共振弹性值与病理分级的关系
Clinics in oncology (Belmont, Calif.) Pub Date : 2021-11-02 DOI: 10.25107/cio-v6-id1873
Zong Li, Chun-Yan Chen M, Dong‐sheng Zhang, Shui-qing Zhuo, Guixiao Xu, Dele Deng, Haibin Liu, B. Liang, Zhixing Lin, Xiao-ting Zhang, Wenxin Zhong, Junyang Huang, C. Xie, Yi-zhuo Li, Hao-qiang He
{"title":"Quantitative Evaluation of the Relationship between Magnetic Resonance Elastic Value and Pathological Grade of Hepatocellular Carcinoma by Magnetic Resonance Elastography","authors":"Zong Li, Chun-Yan Chen M, Dong‐sheng Zhang, Shui-qing Zhuo, Guixiao Xu, Dele Deng, Haibin Liu, B. Liang, Zhixing Lin, Xiao-ting Zhang, Wenxin Zhong, Junyang Huang, C. Xie, Yi-zhuo Li, Hao-qiang He","doi":"10.25107/cio-v6-id1873","DOIUrl":"https://doi.org/10.25107/cio-v6-id1873","url":null,"abstract":"Objectives: To try another non-invasive method to evaluate the relationship between Magnetic Resonance (MR) elastic value and pathological grade of Hepatocellular Carcinoma (HCC) using Magnetic Resonance Elastography (MRE). Methods: Forty-seven HCC patients underwent MR Imaging (MRI), elastography in the upper abdomen. The elastic value of the lesion area was measured, and that of the normal liver tissue was measured adjacent to the lesion area at the same level. The Mann-Whitney U test was used to compare the difference in elasticity between the lesion area and normal area, and the difference between the low and middle-high differentiation groups. The Receiver Operating Characteristic Curve (ROC) of the lesion area and normal area in the complete case group and different differentiation groups were used to determine the diagnostic cut-off value to distinguish the lesion area from the normal area in each group. Results: (1) There was a significant difference in elasticity between the normal area and HCC area (p<0.001). The diagnostic cut-off value was 4842 Pa. (2) There was a significant difference in elasticity between the low-and middle-high differentiation groups (p<0.001). The diagnostic cut-off value was 10456 Pa. (3) There was a statistically significant correlation between the elastic value on MRE and degree of pathological differentiation of HCC in the two groups (p<0.001). Conclusion: The elastic value of HCC measured using MRE can be used to evaluate the degree of pathological differentiation of HCC. MRE may be a non-invasive and reliable method for evaluating the pathological grade of HCC.","PeriodicalId":91853,"journal":{"name":"Clinics in oncology (Belmont, Calif.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80460974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contralateral Prophylactic Mastectomy Improves Survival Only Marginally in Patients with Unilateral Triple-Negative Breast Cancer: A Cohort Study Based on SEER Database 对侧预防性乳房切除术仅能略微提高单侧三阴性乳腺癌患者的生存率:一项基于SEER数据库的队列研究
Clinics in oncology (Belmont, Calif.) Pub Date : 2021-09-21 DOI: 10.21203/rs.3.rs-900438/v1
Pengcheng Yang, Y. Chu, Qian Li, Tianyu Lei, Jia Song, T. Ning, Q. Hu
{"title":"Contralateral Prophylactic Mastectomy Improves Survival Only Marginally in Patients with Unilateral Triple-Negative Breast Cancer: A Cohort Study Based on SEER Database","authors":"Pengcheng Yang, Y. Chu, Qian Li, Tianyu Lei, Jia Song, T. Ning, Q. Hu","doi":"10.21203/rs.3.rs-900438/v1","DOIUrl":"https://doi.org/10.21203/rs.3.rs-900438/v1","url":null,"abstract":"\u0000 Background: The effect of contralateral prophylactic mastectomy (CPM) on the survival rate of triple-negative breast cancer (TNBC) patients is still controversial. The purpose of this study was to confirm whether unilateral TNBC patients benefit from CPM.Methods: 10006 patients with unilateral TNBC in the Surveillance, Epidemiology and End Results (SEER) database were enrolled in this study, propensity score matching (PSM) was applied to balance patient assignments. After PSM,3039 pairs of patients were divided into a CPM group and no-CPM group, respectively. All the patients have undergone total mastectomy or radical mastectomy. Cox proportional hazards regression models were used to evaluate overall survival (OS) and breast cancer-specific survival (BCSS) of the two groups. Subgroup analysis was introduced to exclude the effect of confounding factors. To identify potential variables for prognosis, Kaplan–Meier survival analysis and Cox regression analysis were used and were presented by Kaplan–Meier curve and forest plot separately.Results: With a median follow‐up time of 34.5months (IQR 1–83 months), the estimated 5-year BCSS rates for patients in the CPM group and the no-CPM group were 81.96% and 78.71%, the 5-year OS rates were 80.10% and 75.05%, respectively. CPM improved the BCSS (hazard ratio [HR]= 0.79; 95% confidence interval [CI]=0.69-0.90, p=0.001) and OS (HR= 0.74; 95% CI=0.66-0.84, p<0.001) of unilateral TNBC patients. Univariate subgroup analyses revealed that there was no significant difference in survival time for patients in stage N3 who underwent CPM or not (p>0.05).Conclusions: CPM only limitedly improved BCSS and OS in patients with unilateral TNBC undergoing total mastectomy or radical mastectomy and was not recommended for stage N3 patients.","PeriodicalId":91853,"journal":{"name":"Clinics in oncology (Belmont, Calif.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73787737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GTV Cochlea Distance to Predict the Feasibility of Dose Limiting in Cochlea Sparing during Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma GTV耳蜗距离预测鼻咽癌调强放疗中耳蜗保留剂量限制的可行性
Clinics in oncology (Belmont, Calif.) Pub Date : 2019-10-10 DOI: 10.25107/2474-1663-v4-id1665
Chao Zhang, Lingling Liu, Wei-zhan Li, W. Liang, Zhao-hui Chen, Xian-hai Huang, J. Qi
{"title":"GTV Cochlea Distance to Predict the Feasibility of Dose Limiting in Cochlea Sparing during Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma","authors":"Chao Zhang, Lingling Liu, Wei-zhan Li, W. Liang, Zhao-hui Chen, Xian-hai Huang, J. Qi","doi":"10.25107/2474-1663-v4-id1665","DOIUrl":"https://doi.org/10.25107/2474-1663-v4-id1665","url":null,"abstract":"*Correspondence: Chao Zhang, Department of Radiation Oncology, Panyu Central Hospital, Guangzhou, China, Tel: +86-02034859206, +86-18926220659; Fax: +86-020-84818098; E-mail: cbsenglish@163.com Received Date: 27 Sep 2019 Accepted Date: 18 Oct 2019 Published Date: 24 Oct 2019 Citation: Zhang C, Liu L-X, Li W-Z, Liang W, Chen Z-H, Huang X-H, et al. GTV Cochlea Distance to Predict the Feasibility of Dose Limiting in Cochlea Sparing during Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma. Clin Oncol. 2019; 4: 1665. Copyright © 2019 Chao Zhang. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Research Article Published: 24 Oct, 2019","PeriodicalId":91853,"journal":{"name":"Clinics in oncology (Belmont, Calif.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84380022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inflammation, Oxidative Stress and Cobalt Deficiency in Acute Childhood Leukemia 急性儿童白血病的炎症、氧化应激和钴缺乏
Clinics in oncology (Belmont, Calif.) Pub Date : 2019-10-10 DOI: 10.25107/2474-1663-v4-id1663
M. Akiibinu, B. Oseni, A. Adesiyan, S. Akiibinu, J. Anetor
{"title":"Inflammation, Oxidative Stress and Cobalt Deficiency in Acute Childhood Leukemia","authors":"M. Akiibinu, B. Oseni, A. Adesiyan, S. Akiibinu, J. Anetor","doi":"10.25107/2474-1663-v4-id1663","DOIUrl":"https://doi.org/10.25107/2474-1663-v4-id1663","url":null,"abstract":"*Correspondence: Moses O Akiibinu, Department of Chemistry and Biochemistry, Caleb University Lagos, G.P.O Box 11379 Dugbe, Ibadan, Oyo state, Nigeria, E-mail: akiibinumoses@yahoo.com Received Date: 05 Sep 2019 Accepted Date: 27 Sep 2019 Published Date: 10 Oct 2019 Citation: Akiibinu MO, Oseni BS, Adesiyan AA, Anetor JI. Inflammation, Oxidative Stress and Cobalt Deficiency in Acute Childhood Leukemia. Clin Oncol. 2019; 4: 1663.","PeriodicalId":91853,"journal":{"name":"Clinics in oncology (Belmont, Calif.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80202294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Removal of a Huge Uterine Mass, Weighing 11000 Grams, In an Elderly Woman with a Minimally Invasive Surgical Approach: Feasibility and Safety 1例老年妇女子宫巨大肿块,重11000克,微创手术切除:可行性和安全性
Clinics in oncology (Belmont, Calif.) Pub Date : 2019-03-21 DOI: 10.25107/2474-1663.ID1596
A. Macciò, G. Chiappe, Fabrizio Lavra, E. Sanna, C. Madeddu
{"title":"Removal of a Huge Uterine Mass, Weighing 11000 Grams, In an Elderly Woman with a Minimally Invasive Surgical Approach: Feasibility and Safety","authors":"A. Macciò, G. Chiappe, Fabrizio Lavra, E. Sanna, C. Madeddu","doi":"10.25107/2474-1663.ID1596","DOIUrl":"https://doi.org/10.25107/2474-1663.ID1596","url":null,"abstract":"Since 1993, when the first Total Laparoscopic Hysterectomy (TLH) was described, surgical treatment for uterine fibroids has changed significantly. Initially, surgeons discussed the feasibility and safety of TLH compared with vaginal and laparotomy approaches. Presently, surgeons are working to better understand the limits of TLH, especially relative to its complexity, when associated with particular clinical conditions, such as presence of adnexal masses, adhesions, endometriosis, and in terms of the size of the uterus to be removed. In recent years, we have been attempting to demonstrate that expert teams can successfully perform TLH of large-sized uteri that were once removed only by laparotomy [1,2]. In 2016, in a large series of large uteri removed laparoscopically, we reported a maximum uterine weight of 4000 g [3]. Subsequently, we described the possibility of laparoscopically removing a uterus weighing 5320 g with the support of a uterine manipulator [4] as well as a uterus weighing 5720 g without the aid of a uterine manipulator [5], both with no complications. Thus far, the weight limit of a uterus that can be removed laparoscopically and the possible complications of such a surgery remain unclear. Here, we describe an 80-year-old patient who underwent laparoscopic removal of a huge uterine mass with cystic degeneration weighing 11000 g.","PeriodicalId":91853,"journal":{"name":"Clinics in oncology (Belmont, Calif.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82578943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metastatic retroperitoneal paraganglioma: Case report and review of the literature. 转移性腹膜后副神经节瘤:病例报告和文献综述。
Clinics in oncology (Belmont, Calif.) Pub Date : 2019-03-01 Epub Date: 2019-03-08
Alexandra L Tabakin, Michael A Weintraub, Kushan D Radadia, Cristo G Salazar, Evita Sadimin, Eric A Singer
{"title":"Metastatic retroperitoneal paraganglioma: Case report and review of the literature.","authors":"Alexandra L Tabakin, Michael A Weintraub, Kushan D Radadia, Cristo G Salazar, Evita Sadimin, Eric A Singer","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Paragangliomas are rare neuroendocrine tumors with 500 to 1600 new cases in the United States each year (1). The clinical presentation may range from asymptomatic to the classic triad of episodic diaphoresis, headache, and palpitations. Surgery is the hallmark of treatment when tumors are amenable to resection. When patients are found to have metastases, systemic therapies may be employed. In this case report, we present a patient found to have a large retroperitoneal paraganglioma with nodal metastases.</p>","PeriodicalId":91853,"journal":{"name":"Clinics in oncology (Belmont, Calif.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554718/pdf/nihms-1028765.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40542414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma. LINGO-1是治疗尤文氏肉瘤的新靶点和生物标志物。
Arvind Jain, Jing Zhang, Terence Rabbitts
{"title":"LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma.","authors":"Arvind Jain,&nbsp;Jing Zhang,&nbsp;Terence Rabbitts","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Ewing sarcoma is a predominantly paediatric cancer with a high rate of metastasis and reoccurrence. A new surface marker called LINGO-1 was recently identified on Ewing tumours as a potential target for antibody-mediated therapies. However, such targeting requires caution because of LINGO-1 expression on some brain cells. Although the blood-brain-barrier exists, small amounts of antibody may cross this barrier and cause harmful side-effects. In this perspective, we suggest some options to alleviate this risk that can make targeting tumour cells expressing the LINGO-1 antigen a safe option.</p>","PeriodicalId":91853,"journal":{"name":"Clinics in oncology (Belmont, Calif.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314441/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36839548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NMR Metabolomics in Ionizing Radiation. 电离辐射中的核磁共振代谢组学。
Clinics in oncology (Belmont, Calif.) Pub Date : 2016-01-01 Epub Date: 2016-09-08
Jian Zhi Hu, Xiongjie Xiao, Mary Y Hu
{"title":"NMR Metabolomics in Ionizing Radiation.","authors":"Jian Zhi Hu,&nbsp;Xiongjie Xiao,&nbsp;Mary Y Hu","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":91853,"journal":{"name":"Clinics in oncology (Belmont, Calif.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505640/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35169273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信